Literature DB >> 8837363

First case of HIV-1 group O infection in Spain.

V Soriano, M Gutiérrez, G García-Lerma, O Aguilera, A Mas, R Bravo, M L Pérez-Labad, M Baquero, J González-Lahoz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8837363     DOI： 10.1046/j.1423-0410.1996.7110066.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  9 in total

1.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection.

Authors:  Marie Gueudin; Marie Leoz; Véronique Lemée; Fabienne De Oliveira; Aurélia Vessière; Anfumbom Kfutwah; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

5.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

7.  Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

Authors:  M E Quiñones-Mateu; J L Albright; A Mas; V Soriano; E J Arts
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integrase.

Authors:  Agnès Depatureaux; Peter K Quashie; Thibault Mesplède; Yingshan Han; Hannah Koubi; Jean-Christophe Plantier; Maureen Oliveira; Daniela Moisi; Bluma Brenner; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

Review 9.  AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

Authors:  Vicente Soriano; José M Ramos; Pablo Barreiro; Jose V Fernandez-Montero
Journal:  Viruses       Date:  2018-05-30       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.